CA Patent

CA3173027A1 — Multi-unit drug delivery devices and methods

Assigned to Taris Biomedical LLC · Expires 2015-02-26 · 11y expired

What this patent protects

MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS Abstract of the Disclosure Implantable drug delivery devices include a housing defining a reservoir, a first unit within the reservoir, and a second unit within the reservoir. The first unit contains a drug and the second unit contains…

USPTO Abstract

MULTI-UNIT DRUG DELIVERY DEVICES AND METHODS Abstract of the Disclosure Implantable drug delivery devices include a housing defining a reservoir, a first unit within the reservoir, and a second unit within the reservoir. The first unit contains a drug and the second unit contains a functional agent that facilitates release of the drug. Intravesical drug delivery devices include a housing portion containing a drug formulation and a housing portion containing an excipient, and are configured to release the drug according to a first release profile and the excipient according to a second release profile. Methods include inserting any of these devices into a patient and releasing drug from the device. Date Regue/Date Received 2022-09-06

Drugs covered by this patent

Patent Metadata

Patent number
CA3173027A1
Jurisdiction
CA
Classification
—
Expires
2015-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Taris Biomedical LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.